JanOne Inc (JAN)

[Principian]

Phase 2B Clinical Trials. Invesyors should familiarize yourselves with the Approval processes.

https://en.m.wikipedia.org/wiki/Phases_of_clinical_research

I find it interesting on the statistics being presented. According to the above link approximately 18% of the Drugs make it out of the Phase 2 Trial and approximately only 50% make it past Phase 3.

It would be worth while to understand in this case who actually is taking on the monetary risks. The above link also indicates these phases are the most costly to go thru. Phase 3 being the most costly and Time Consuming.

An investor would have to consider the timeframes for a return on their investments.

It also will be interesting to understand exactly what this Chief Scientist is getting out of this from ARCI/JAN.

Question I have is he still appears to be the CEO of Theravasc so why get into bed with a company such as ARCI/JAN. There is no announcements he is stepping down. So to me this is only a move to build Marketing Creditability.

I dont know enough about the Biotech Industry, but something just like Geotraq here doesn't smell right.